Skip to main content

CIDARA IS DEVELOPING LONG-ACTING THERAPEUTICS DESIGNED TO SAVE LIVES AND IMPROVE THE STANDARD OF CARE FOR PATIENTS FACING SERIOUS DISEASES

Antifungal:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections.

Proprietary
Technology Platform

Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit specific disease targets while simultaneously engaging the immune system.

Cidara is developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases.

Antifungal:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections.

Proprietary
Technology Platform

Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit specific disease targets while simultaneously engaging the immune system.

PIPELINE

RECENT NEWS